First in Human, Dose Escalation Study of AN4005

Clinical trial NCT04999384 · RECRUITING

Trial details

NCT number: NCT04999384
Sponsor: Adlai Nortye Biopharma Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumor Advanced Lymphoma

Start date: 2021-09-27
Primary completion: 2026-11-01
Enrollment: 31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.